Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia

NCT00081887 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Chronic Lymphocytic Leukemia
Leukemia

Interventions

DRUG: Clofarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]